TGen discovers potential drug targets to reduce pain in pancreatic cancer patients
PHOENIX, Ariz. -- Nov. 7, 2016 -- The Translational Genomics Research Institute (TGen) has discovered potential drug targets to reduce pain in pancreatic cancer patients....